UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 691

Sortiert nach

Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial

Gut, 2000-04, Vol.46 (4), p.562-568

2000

Volltextzugriff (PDF)

Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B

Gut, 2000-03, Vol.46 (3), p.420-426

2000

Volltextzugriff (PDF)

Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy

Gut, 2004-10, Vol.53 (10), p.1504-1508

2004

Volltextzugriff (PDF)

Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients

Gastroenterology (New York, N.Y. 1943), 1997-02, Vol.112 (2), p.463-472

1997

Volltextzugriff (PDF)

Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection

Journal of viral hepatitis, 2003-07, Vol.10 (4), p.294-297

2003

Volltextzugriff (PDF)

Determinants of quality of life in chronic liver patients

Alimentary pharmacology & therapeutics, 2006-06, Vol.23 (11), p.1629-1635

2006

Volltextzugriff (PDF)

Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon α-2b therapy

Gut, 2005-11, Vol.54 (11), p.1604-1609

2005

Volltextzugriff (PDF)

Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase

Gut, 2003-03, Vol.52 (3), p.420-424

2003

Volltextzugriff (PDF)

Acute liver failure: redefining the syndromes

The Lancet (British edition), 1993-07, Vol.342 (8866), p.273-275

1993

Volltextzugriff (PDF)

The safety of pegylated interferon alpha‐2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation

Alimentary pharmacology & therapeutics, 2005-05, Vol.21 (9), p.1163-1171

2005

Volltextzugriff (PDF)

Subclinical hepatic encephalopathy impairs daily functioning

Hepatology (Baltimore, Md.), 1998-07, Vol.28 (1), p.45-49

1998

Volltextzugriff (PDF)

Acute Exacerbation of Chronic Hepatitis B Virus Infection After Withdrawal of Lamivudine Therapy

Hepatology (Baltimore, Md.), 2000-09, Vol.32 (3), p.635-639

2000

Volltextzugriff (PDF)

Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection

Journal of viral hepatitis, 2007-01, Vol.14 (1), p.29-35

2007

Volltextzugriff (PDF)

European collaborative study on factors influencing outcome after liver transplantation for hepatitis C

Gastroenterology (New York, N.Y. 1943), 1999-09, Vol.117 (3), p.619-625

1999

Volltextzugriff (PDF)

Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias

The Journal of pathology, 2000-10, Vol.192 (2), p.207-215

2000

Volltextzugriff (PDF)

Different composition of intrahepatic lymphocytes in the immune-tolerance and immune-clearance phase of chronic hepatitis B

Journal of medical virology, 2006-05, Vol.78 (5), p.561-568

2006

Volltextzugriff (PDF)

The prognostic significance of subclinical hepatic encephalopathy

The American journal of gastroenterology, 2000-08, Vol.95 (8), p.2029-2034

2000

Volltextzugriff (PDF)

Ten-year neonatal hepatitis B vaccination program, the Netherlands, 1982–1992: protective efficacy and long-term immunogenicity

Vaccine, 1997-10, Vol.15 (15), p.1624-1630

1997

Volltextzugriff (PDF)

Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients

Journal of clinical virology, 2003-08, Vol.27 (3), p.213-230

2003

Volltextzugriff (PDF)

Screening of subclinical hepatic encephalopathy

Journal of hepatology, 2000-05, Vol.32 (5), p.748-753

2000

Volltextzugriff (PDF)

Lamivudine resistance in immunocompetent chronic hepatitis B : Incidence and patterns

Journal of hepatology, 1997-06, Vol.26 (6), p.1393-1395

1997

Volltextzugriff (PDF)

Long‐term outcome of hepatitis B e antigen–positive patients with compensated cirrhosis treated with interferon alfa

Hepatology (Baltimore, Md.), 1997-11, Vol.26 (5), p.1338-1342

1997

Volltextzugriff (PDF)

Review article : glycyrrhizin as a potential treatment for chronic hepatitis C

Alimentary pharmacology & therapeutics, 1998-03, Vol.12 (3), p.199-205

1998

Volltextzugriff (PDF)

Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C: Meta-analysis of individual patient data from European centers

Journal of hepatology, 1997-05, Vol.26 (5), p.961-966

1997

Volltextzugriff (PDF)

Intravenous glycyrrhizin for the treatment of chronic hepatitis C: A double-blind, randomized, placebo-controlled phase I/II trial

Journal of gastroenterology and hepatology, 1999-11, Vol.14 (11), p.1093-1099

1999

Volltextzugriff (PDF)

1 – 25 von 691

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(609)
Mit Volltextzugriff
(460)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(406)
Science & Technology
(392)
Life Sciences & Biomedicine
(381)
Female
(262)
Biological And Medical Sciences
(226)
Male
(221)
Medical Sciences
(216)
Adult
(194)
Gastroenterology & Hepatology
(187)
Middle Aged
(174)
Animals
(108)
Infectious Diseases
(104)
Antiviral Agents - Therapeutic Use
(102)
Viral Diseases
(81)
Aged
(80)
Human Viral Diseases
(79)
Viral Hepatitis
(78)
Interferon-Alpha - Therapeutic Use
(75)
Pharmacology. Drug Treatments
(73)
Gastroenterology. Liver. Pancreas. Abdomen
(62)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial

Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B

Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy

Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients

Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection

Determinants of quality of life in chronic liver patients

Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon α-2b therapy

Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase

Acute liver failure: redefining the syndromes

The safety of pegylated interferon alpha‐2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation

Subclinical hepatic encephalopathy impairs daily functioning

Acute Exacerbation of Chronic Hepatitis B Virus Infection After Withdrawal of Lamivudine Therapy

Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection

European collaborative study on factors influencing outcome after liver transplantation for hepatitis C

Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias

Different composition of intrahepatic lymphocytes in the immune-tolerance and immune-clearance phase of chronic hepatitis B

The prognostic significance of subclinical hepatic encephalopathy

Ten-year neonatal hepatitis B vaccination program, the Netherlands, 1982–1992: protective efficacy and long-term immunogenicity

Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients

Screening of subclinical hepatic encephalopathy

Lamivudine resistance in immunocompetent chronic hepatitis B : Incidence and patterns

Long‐term outcome of hepatitis B e antigen–positive patients with compensated cirrhosis treated with interferon alfa

Review article : glycyrrhizin as a potential treatment for chronic hepatitis C

Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C: Meta-analysis of individual patient data from European centers

Intravenous glycyrrhizin for the treatment of chronic hepatitis C: A double-blind, randomized, placebo-controlled phase I/II trial

Suchergebnisse filtern